Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares dropped 11.8% on Monday . The stock traded as low as C$12.00 and last traded at C$12.10. Approximately 1,571,263 shares traded hands during mid-day trading, an increase of 265% from the average session volume of 430,291 shares. The stock had previously closed at C$13.71.
Ondine Biomedical Stock Down 11.8%
The stock has a market cap of C$6.29 billion, a price-to-earnings ratio of -2.02 and a beta of 0.31. The firm’s fifty day moving average price is C$14.01 and its two-hundred day moving average price is C$12.38. The company has a debt-to-equity ratio of 11.85, a current ratio of 1.23 and a quick ratio of 8.26.
Ondine Biomedical Company Profile
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.
Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.
Further Reading
- Five stocks we like better than Ondine Biomedical
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
- D-Wave Has Momentum—What Does It Need to Keep It Going?
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
